Endpoints News
Novartis' rollout plans for malaria med for babies Read in browser
Endpoints News
Thank you for reading, dupa dupackia!
basic
UPGRADE
M Tue W Th F
8 July, 2025
2025'S BREAKOUT STARTUPS. WHO'S ON THE LIST?
The biotech companies everyone will be talking about in 2025 get revealed live in Boston this September. Endpoints 11 isn’t just any list — it’s where industry insiders gather to see which bold bets might pay off. Find out who wins in real time at the State Room — reserve your spot now and save with the Early Bird rate.
presented by Biogen
Un­cov­er­ing the Po­ten­tial of Tar­get­ing the CD38 Path­way for Im­mune-Me­di­at­ed Dis­eases
news
Shell company Concentra has found its rhythm, with Cargo Therapeutics as its latest buyout target
ENDPOINTS NEWS
Novartis maps launch of malaria drug for newborns after Swiss approval
ENDPOINTS NEWS
Singaporean biotech gets China thumbs-up for study of potentially curative HBV cell therapy
ENDPOINTS NEWS
FDA chief calls for 'meaningful' reduction of animal testing for new drugs
ENDPOINTS NEWS
Endpoints webinars
Jul 10
11:00am ET
Beyond the data deluge: Immune profiling in early immuno-oncology trials
Precision for Medicine
Jul 22
2:00pm ET
New data from ASCO 2025 & clinical performance of Natera’s ultra-sensitive MRD platform
Natera
Jul 24
12:00pm ET
Predict tumor response and identify more patients for therapy with epigenomic biomarkers
Guardant
POST-HOC DISPATCHES FROM THE NEWSROOM
Post-Hoc Live is now available to stream. Catch full episodes on YouTube or listen on Spotify and Apple Podcasts. Be sure to subscribe so you don’t miss what’s next.
endpoints pharma
KalVista CEO says FDA review proceeded normally, was unaware of Makary's rejection ask
ENDPOINTS NEWS
 
Despite delay, KalVista wins FDA approval after Makary's short-lived attempt to intervene
ENDPOINTS NEWS
Trump's tax cut law expands orphan drug exclusions, could upend 340B program
ENDPOINTS NEWS
The Supreme Court passed on a state PBM case. Lawyers say a broader legal fight is brewing
ENDPOINTS NEWS
Clinician groups sue RFK Jr. and HHS over Covid-19 vaccine recommendation changes
ENDPOINTS NEWS
in case you missed it
1.
Compromised drug lot impacts Jasper's chronic hives study, stock falls
ENDPOINTS NEWS
2.
Apogee reports Phase 2 win for eczema drug that could challenge Sanofi’s Dupixent and Lilly’s Ebglyss
ENDPOINTS NEWS
3.
Cogent’s mastocytosis drug hits ‘home run’ in registrational mid-stage trial
ENDPOINTS NEWS
4.
Roche-backed Chugai taps into longevity field with Pfizer-allied Gero
ENDPOINTS NEWS
5.
European Commission fines Alchem, closes API ‘cartel’ investigation 
ENDPOINTS NEWS
6.
Tell the Bot to Tell the Bot About the Bot
Derek Lowe, In the Pipeline
7.